Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression

NCT06052137 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT06052137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06052137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 19, 2023
Completion date
October 31, 2025
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression